TRMK Stock Analysis: Trustmark | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 2.728m USD | 12M Return: 23.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 20.7M
EPS Trend: 84.8%
Qual. Beats: 2
Rev. Trend: 71.6%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Trustmark Corporation (NASDAQ: TRMK) is a bank holding company for Trustmark National Bank, providing banking and financial solutions to individuals and corporate clients across the United States. Founded in 1889 and headquartered in Jackson, Mississippi, the company operates through two main segments: General Banking and Wealth Management. Its offerings span deposit products (checking, savings, money market accounts, certificates of deposit, and IRAs), treasury management, and a diverse loan portfolio covering commercial and industrial lending, commercial and owner-occupied real estate, construction and land development, and installment and real estate loans. Trustmark also provides mortgage banking services, trust and wealth management offerings for individuals, employee benefit plans, and foundations, as well as institutional custody, financial and estate planning, and retirement plan services. In addition, the company acts as an intermediary for loans and investments in low-income communities, a function typical of regional banks that operate under Community Reinvestment Act obligations.
As a mid-cap regional bank in the Financials sector, Trustmarks business model combines traditional interest-generating lending with fee-based revenue from wealth management and mortgage banking, allowing it to diversify income beyond net interest margin.
- Net interest margin compresses amid rising deposit costs
- Commercial real estate loan losses pressure credit quality
- Mortgage banking revenue softens on lower origination volumes
| Net Income: 226.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.36 > 1.0 |
| NWC/Revenue: -247.8% < 20% (prev -1.58k%; Δ 1.33k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 188.6m > Net Income 226.6m |
| Net Debt (458.5m) to EBITDA (329.9m): 1.39 < 3 |
| Current Ratio: 0.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.1m) vs 12m ago -3.25% < -2% |
| Gross Margin: 66.38% > 18% (prev 52.55%; Δ 13.82% > 0.5%) |
| Asset Turnover: 6.40% > 50% (prev 4.55%; Δ 1.85% > 0%) |
| Interest Coverage Ratio: 0.78 > 6 (EBIT TTM 286.0m / Interest Expense TTM 366.7m) |
| A: -0.16 (Total Current Assets 526.6m - Total Current Liabilities 3.48b) / Total Assets 19.0b |
| B: 0.11 (Retained Earnings 2.08b / Total Assets 19.0b) |
| C: 0.02 (EBIT TTM 286.0m / Avg Total Assets 18.6b) |
| D: 0.13 (Book Value of Equity 2.13b / Total Liabilities 16.9b) |
| Altman-Z'' = -0.43 = B |
As of July 08, 2026, the stock is trading at USD 46.23 with a total of 289,503 shares traded. Over the past week, the price has changed by +0.37%, over one month by +4.26%, over three months by +7.25% and over the past year by +23.76%.
Current recommended Stop Loss: 44.50 (which is 3.7% or 1.8 ATR below the current price).
Trustmark has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold TRMK.
- StrongBuy: 1
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 47.5 | 2.6% |
P/E Trailing = 12.3475
P/E Forward = 11.8906
P/S = 3.4073
P/B = 1.2761
P/EG = 2.2868
Revenue TTM = 1.19b USD
EBIT TTM = 286.0m USD
EBITDA TTM = 329.9m USD
Long Term Debt = 526.4m USD (from longTermDebt, last quarter)
Short Term Debt = 385.0m USD (from shortTermDebt, last quarter)
Debt = 985.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 36.8m
Net Debt = 458.5m USD (calculated: Debt 985.1m - CCE 526.6m)
Enterprise Value = 3.19b USD (2.73b + Debt 985.1m - CCE 526.6m)
Interest Coverage Ratio = 0.78 (Ebit TTM 286.0m / Interest Expense TTM 366.7m)
EV/FCF = 18.49x (Enterprise Value 3.19b / FCF TTM 172.4m)
FCF Yield = 5.41% (FCF TTM 172.4m / Enterprise Value 3.19b)
FCF Margin = 14.45% (FCF TTM 172.4m / Revenue TTM 1.19b)
Net Margin = 19.00% (Net Income TTM 226.6m / Revenue TTM 1.19b)
Gross Margin = 66.38% ((Revenue TTM 1.19b - Cost of Revenue TTM 401.0m) / Revenue TTM)
Gross Margin QoQ = 73.21% (prev 72.56%)
Tobins Q-Ratio = 0.17 (Enterprise Value 3.19b / Total Assets 19.0b)
Interest Expense / Debt = 37.23% (Interest Expense 366.7m / Debt 985.1m)
Taxrate = 20.77% (59.4m / 286.0m)
NOPAT = 226.6m (EBIT 286.0m * (1 - 20.77%))
Current Ratio = 0.15 (Total Current Assets 526.6m / Total Current Liabilities 3.48b)
Debt / Equity = 0.46 (Debt 985.1m / totalStockholderEquity, last quarter 2.13b)
Debt / EBITDA = 1.39 (Net Debt 458.5m / EBITDA 329.9m)
Debt / FCF = 2.66 (Net Debt 458.5m / FCF TTM 172.4m)
Total Stockholder Equity = 2.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.22% (Net Income 226.6m / Total Assets 19.0b)
RoE = 10.75% (Net Income TTM 226.6m / Total Stockholder Equity 2.11b)
RoCE = 10.85% (EBIT 286.0m / Capital Employed (Equity 2.11b + L.T.Debt 526.4m))
RoIC = 1.20% (NOPAT 226.6m / Invested Capital 18.9b)
WACC = 14.18% (E(2.73b)/V(3.71b) * Re(8.65%) + D(985.1m)/V(3.71b) * Rd(37.23%) * (1-Tc(0.21)))
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.44 | Cagr: -1.63%
[DCF] Terminal Value 54.65% ; FCFF base≈196.3m ; Y1≈172.1m ; Y5≈139.1m
[DCF] Fair Price = 11.81 (EV 1.15b - Net Debt 458.5m = Equity 692.1m / Shares 58.6m; r=14.18% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 84.85 | EPS CAGR: 13.73% | SUE: 2.60 | # QB: 2
Revenue Correlation: 71.65 | Revenue CAGR: 12.27% | SUE: 0.56 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.96 | Chg30d=+0.17% | Revisions=+25% | Analysts=6
EPS next Quarter (2026-09-30): EPS=1.00 | Chg30d=+0.00% | Revisions=+29% | Analysts=6
EPS current Year (2026-12-31): EPS=3.90 | Chg30d=+0.00% | Revisions=+62% | GrowthEPS=+5.5% | GrowthRev=+4.8%
EPS next Year (2027-12-31): EPS=4.09 | Chg30d=-0.24% | Revisions=-25% | GrowthEPS=+4.7% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +50% (up=9, down=2)